Russia has granted regulatory approval to a vaccine against COVI-19, but the vaccine hasn’t been thoroughly tested. Gary Kobinger, an infectious disease expert who helped develop an Ebola vaccine, tells Marco Werman about the dangers of cutting corners in a vaccine trial.
Sign up for The Top of the World, delivered to your inbox every weekday morning.